Mark Schecker, M.D.
Allergy Physician in Myrtle Beach, South Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,015 in Allergy Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
What the federal data shows
Mark Schecker, M.D. reported a CMS MIPS final score of 94.7/100 - above the 83.5 national average - and filed 2,913 Medicare Part D claims in 2024.
- 94.7/100
- MIPS score · +11 vs avg
- 3K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥73rd
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Schecker, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1023014057), first enumerated 06/23/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,913 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 94.7/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$125 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1023014057 · Allergy Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-ELITE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1023014057
- ENUM-LEGACY 2005
- TAX-NARROW 1,015
- MIPS-ELITE 94.7/100
- RX-MID 2,913
- BOOK-THIN 14 in South Carolina
- PHOTO-FINISH Laura Esswein, MD · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Michael McCormic…
Michael McCormick, M.D.
94.4 MIPS pts
- Laura Esswein, M…
Laura Esswein, MD
94.6 MIPS pts
- Kim Waterhouse, …
Kim Waterhouse, M.D.
94.6 MIPS pts
- Schecker · this …
Schecker · this provider
94.7 MIPS pts
- Margaret Co, MD …
Margaret Co, MD
95 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Schecker, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
95 ≥ 73rd percentile 73% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Schecker, M.D. sits
This provider among allergy physician peers
Across the 143 allergy physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Schecker, M.D. writes more Part D claims than 92% of them and scores higher on MIPS quality than 80% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one allergy physician peer from a representative sample of 60; the gold marker is Mark Schecker, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Mark Schecker, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Schecker, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in South Carolina
How Allergy Physician compares to other specialties among South Carolina providers
Allergy Physician ranks #236 among South Carolina's specialties (0% of in-state providers)
Each bar is a specialty's share of the South Carolina provider total, by primary NUCC taxonomy. The highlighted bar is Allergy Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Mark Schecker, M.D.'s 2023 MIPS final score plotted against the Allergy Physician national average
- MIPS Final Score
- 94.7/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Allergy Physician US NPIs
94.7/100 MIPS final score - 11.2 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Allergy Physician. Quality dim: 100. Cost dim: 82.2.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1023014057 |
|---|---|
| Specialty | Allergy Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/23/2005 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mark Schecker, M.D.'s current license status, disciplinary history, and board certifications with the South Carolina Board of Medical Examiners in South Carolina before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1023014057 is the unique 10-digit identifier CMS uses to link Schecker across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Schecker, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$125
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 5,492.633
- Total Day Supply
- 158,323
- Generic Drug Cost
- $84K
- Antibiotic Claims
- 67
Patient Demographics
- Average Patient Age
- 73.7 years
- Avg HCC Risk Score
- 0.97
- Gender Split
- 67% female / 33% male
- Age Distribution
- <65: 21, 65-74: 287, 75-84: 216, 85+: 30
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mark Schecker, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Fluticasone Propio…
Fluticasone Propionate
378 claims
- Levocetirizine Dih…
Levocetirizine Dihydrochloride
365 claims
- Ipratropium Bromide
Ipratropium Bromide
327 claims
- Azelastine Hcl
Azelastine Hcl
326 claims
- Montelukast Sodium
Montelukast Sodium
220 claims
- Albuterol Sulfate … 148
Albuterol Sulfate Hfa
148 claims
- Breo Ellipta 148
Breo Ellipta
148 claims
- Trelegy Ellipta 132
Trelegy Ellipta
132 claims
| Drug | Claims |
|---|---|
| Fluticasone Propionate | 378 |
| Levocetirizine Dihydrochloride | 365 |
| Ipratropium Bromide | 327 |
| Azelastine Hcl | 326 |
| Montelukast Sodium | 220 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 148 |
| Breo Ellipta Fluticasone/Vilanterol | 148 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 132 |
| Olopatadine Hcl | 103 |
| Arnuity Ellipta Fluticasone Furoate | 92 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy Physician Overview
How Mark Schecker, M.D. fits within the Allergy Physician landscape nationally.
Mark Schecker, M.D.'s 2,913 claims are above the specialty average of 805.
Nationwide Allergy Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Schecker, both outside South Carolina so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (94.7 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Allergy Physician Providers in South Carolina
Other clinicians with the same primary specialty enrolled in South Carolina, drawn from the same CMS NPPES roster as Schecker.
One of 14 Allergy Physician providers enrolled in South Carolina, 5 are shown here.
Compare Allergy Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Schecker, M.D.'s specialty? ▼
How much does Mark Schecker, M.D. prescribe under Medicare Part D? ▼
What is Mark Schecker, M.D.'s Medicare quality score? ▼
Where is Mark Schecker, M.D. located? ▼
What is Mark Schecker, M.D.'s NPI number? ▼
How many Allergy Physician providers are there in the US? ▼
What drugs does Mark Schecker, M.D. prescribe most often? ▼
Does Mark Schecker, M.D. accept Medicare? ▼
How can I verify Mark Schecker, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.